Genetic analysis has also demonstrated that single-nucleotide polymorphisms in the non-coding region of AQP4 are associated with an altered rate of cognitive decline after the diagnosis of AD [47], suggesting that alteration of the glymphatic system might be a causative factor for development of AD. The gene discussed is AQP4; the disease is Alzheimer disease.